Skip to content

Immediate Post-placental Insertion of IUCD During Cesarean Delivery Versus 6 Week Post-Cesarean Insertion

: Immediate Post-placental Insertion of the Intrauterine Contraceptive Device During Cesarean Delivery Versus 6 Week Post-Cesarean Insertion

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03404622
Enrollment
200
Registered
2018-01-19
Start date
2016-09-20
Completion date
2017-12-20
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Complication of Intrauterine Device

Brief summary

The aim of current study is to compare the rates of IUCD expulsion and complications in immediate post-placental insertion versus delayed IUCD insertion (6-weeks after cesarean delivery)

Detailed description

Intrauterine devices (IUDs) are among the most effective forms of contraception, offering greater than 99% efficacy per year of use and are completely reversible . Post-placental intrauterine device (IUD) insertion is a safe, convenient, and effective option for postpartum contraception. Post-placental refers to insertion within 10-15 minutes of placental delivery, after vaginal or cesarean delivery.

Interventions

DRUGIUCD

IUCD will be inserted in 100 women post placental removal and will be inserted in anther 100 women after six weeks post cesarean delivery

Sponsors

ALshaimaa Aboalhassan Ali
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Caregiver)

Masking description

Randomization will be based on the sequence generation created by computer and randomization tablets. Consenting patients fulfilling inclusion criteria will be randomizes into one of the following 2 groups. Randomized allocation will be kept in opaque sealed envelopes, with enrollment numbers written on the envelopes. the envelopes will contain a card on with the designated study group will be written. after enrollment of the patients in the study , the envelopes marked with study number will be unsealed and the patients allocated to either groups

Intervention model description

200 pregnant women will be included in this study, will be divided into two groups Group 1 IUCD will be inserted immediate post-placental removal and include 100 pregnant women Group2 IUCD will be inserted 6 weeks postpartum and include 100 pregnant women.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 18 -45 * Singleton pregnancy at ≥32 weeks gestation at time of enrollment * Voluntarily requesting to IUD placement for postpartum contraception * Able to give consent and agree to the terms of the study

Exclusion criteria

1. Uterine anomaly that preventing replacement of IUD. 2. Chorioamnionitis (such as prolonged rupture of membranes \>18 hours, prolonged labor \>24 hours, fever \>38C). 3. Puerperal sepsis and unresolved postpartum hemorrhage. 4. IUD allergy (copper). 5. Systemic lupus erythematosus with severe thrombocytopenia

Design outcomes

Primary

MeasureTime frameDescription
Expulsion3 monthsThe time until expulsion of the IUD will be defined as the time from insertion until expulsion occurred, if known. If the date of expulsion is not known, this will be documented as the day after the IUD was last known to be in place. If a pregnancy is detected and the IUD is absent (and the participant was unaware of expulsion), the expulsion will be assumed to have occurred at the time of conception, as determined by gestational age on ultrasound. Expulsions will be measured as total expulsions and separately noted whether complete or partial

Secondary

MeasureTime frameDescription
Displacement3 monthsThe displacement is diagnosed by doing trans-vaginal ultrasound that showed IUCD that displaced up or down word
Infection3 monthsThe diagnosis of PID will be made based on the 2006 CDC guidelines and the criteria used in the PEACH study.
Bleeding3 monthsIrregular bleeding (including spotting, light bleeding, heavy or longer menstrual period) are common in the first 3 months and may persist.
Perforation3 monthsThe diagnosis of a perforation may be made by a transvaginal sonogram that shows no IUD within the uterus and an abdominal radiograph that show IUD within the abdominal cavity.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026